Fauci Gets Covid Then Gets It Again After Taking Paxlovid



Anthony Fauci, a proponent of mask wear who is fully immunized and double-boosted, is experiencing a double or maybe triple Covid attack.

ZeroHedge revealed two weeks ago that COVID had affected President Biden’s top medical advisor.

According to reports, the 81-year-old had “minor symptoms,” but of course he “spoke the party line words,” saying “it would have been worse if I wasn’t vaccinated.”

Fauci, of course, adhered to the CDC recommendations and took Paxlovid, the government-approved medicine, because of his advanced age and potential infection dangers.

So, shouldn’t that have been the end of it?

But no. Fauci acknowledged he had a bad experience at a Global Health Forum session hosted by Foreign Policy:

“I reverted to negative on an antigen test for three days in a row after I finished the five days of Paxlovid,” Fauci revealed on Tuesday.

“And then, on the fourth day, I tested myself once again to make sure. I changed back to testing positive.

Fauci surprisingly acknowledged:

“…based on additional clinical research, this is becoming more and more typical.”

According to Bloomberg, several patients have complained about the occurrence known as Covid rebound or Paxlovid rebound, in which symptoms reappear after taking the entire recommended dosage of Pfizer’s medication.

Although Pfizer CEO Albert Bourlas suggested in May that doctors might recommend a second round of therapy for these patients, US drug authorities have indicated there is no proof that a repeat will be beneficial.

However, Fauci claimed that after suffering symptoms that were “far worse than in the first time around,” he began taking a second course of Paxlovid.

He stated that the five-day oral therapy was almost through and although he was still experiencing symptoms, he felt “pretty well.”

Finally, as we noted less than two weeks ago, Pfizer halted recruiting patients for a clinical trial of Paxlovid for standard-risk COVID-19 patients after the most recent findings revealed the medication did not statistically significantly reduce symptoms, hospitalizations, or fatalities.

Rephrased from ZeroHedge, by InfoArmed

 

Leave a Comment